REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,467,068 | +17.6% | 53,001 | +13.7% | 0.00% | 0.0% |
| Q2 2023 | $1,247,165 | -45.8% | 46,623 | -56.1% | 0.00% | 0.0% |
| Q1 2023 | $2,301,960 | +11.7% | 106,277 | +22.8% | 0.00% | 0.0% |
| Q4 2022 | $2,061,573 | +26.8% | 86,548 | +4.9% | 0.00% | 0.0% |
| Q3 2022 | $1,626,000 | -0.2% | 82,472 | -1.4% | 0.00% | 0.0% |
| Q2 2022 | $1,630,000 | -26.1% | 83,665 | -3.3% | 0.00% | 0.0% |
| Q1 2022 | $2,207,000 | -2.9% | 86,508 | -4.2% | 0.00% | 0.0% |
| Q4 2021 | $2,272,000 | -7.6% | 90,263 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $2,459,000 | -28.9% | 89,356 | -18.0% | 0.00% | -50.0% |
| Q2 2021 | $3,458,000 | -5.4% | 108,985 | +36.7% | 0.00% | 0.0% |
| Q1 2021 | $3,657,000 | +174.3% | 79,712 | +136.8% | 0.00% | +100.0% |
| Q4 2020 | $1,333,000 | +82.4% | 33,667 | +60.3% | 0.00% | 0.0% |
| Q3 2020 | $731,000 | +211.1% | 21,001 | +182.4% | 0.00% | – |
| Q2 2020 | $235,000 | +119.6% | 7,436 | +51.6% | 0.00% | – |
| Q1 2020 | $107,000 | – | 4,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |